AIRLINK 197.55 Increased By ▲ 7.91 (4.17%)
BOP 10.27 Increased By ▲ 0.18 (1.78%)
CNERGY 6.95 Increased By ▲ 0.27 (4.04%)
FCCL 34.42 Increased By ▲ 0.28 (0.82%)
FFL 17.66 Increased By ▲ 0.57 (3.34%)
FLYNG 24.60 Increased By ▲ 0.77 (3.23%)
HUBC 127.73 Increased By ▲ 1.68 (1.33%)
HUMNL 13.83 Increased By ▲ 0.04 (0.29%)
KEL 4.88 Increased By ▲ 0.11 (2.31%)
KOSM 6.69 Increased By ▲ 0.11 (1.67%)
MLCF 44.15 Increased By ▲ 0.87 (2.01%)
OGDC 224.91 Decreased By ▼ -0.05 (-0.02%)
PACE 7.50 Increased By ▲ 0.12 (1.63%)
PAEL 42.86 Increased By ▲ 1.12 (2.68%)
PIAHCLA 17.22 Increased By ▲ 0.03 (0.17%)
PIBTL 8.54 Increased By ▲ 0.13 (1.55%)
POWER 9.12 Increased By ▲ 0.07 (0.77%)
PPL 194.30 Increased By ▲ 1.21 (0.63%)
PRL 38.76 Increased By ▲ 1.42 (3.8%)
PTC 24.34 Increased By ▲ 0.32 (1.33%)
SEARL 99.87 Increased By ▲ 5.33 (5.64%)
SILK 1.00 Increased By ▲ 0.01 (1.01%)
SSGC 43.76 Increased By ▲ 3.83 (9.59%)
SYM 18.58 Increased By ▲ 0.81 (4.56%)
TELE 9.12 Increased By ▲ 0.46 (5.31%)
TPLP 12.96 Increased By ▲ 0.57 (4.6%)
TRG 64.10 Increased By ▲ 1.45 (2.31%)
WAVESAPP 10.37 Increased By ▲ 0.09 (0.88%)
WTL 1.78 Increased By ▲ 0.03 (1.71%)
YOUW 4.02 Increased By ▲ 0.05 (1.26%)
BR100 11,968 Increased By 154.1 (1.3%)
BR30 36,684 Increased By 449.7 (1.24%)
KSE100 114,230 Increased By 982.8 (0.87%)
KSE30 35,984 Increased By 272.3 (0.76%)
World

AstraZeneca says it will work with Dutch over vaccine queries

  • "Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.
Published April 2, 2021

LONDON: AstraZeneca said on Friday it was working with Dutch authorities to address any questions they had after the Netherlands temporarily suspended use of its COVID-19 vaccine for people under 60 following the death of a woman who had received a shot.

"Regulatory authorities in the UK, European Union, the World Health Organization have concluded that the benefits of using our vaccine to protect people from this deadly virus significantly outweigh the risks across all adult age groups," a spokesman for AstraZeneca said in a statement.

"Tens of millions of people have now received our vaccine across the globe. The extensive body of data from two large clinical datasets and real-world evidence demonstrate its effectiveness, reaffirming the role the vaccine can play during this public health crisis."

Comments

Comments are closed.